Evidence map›Paper›PMID 40430016›Full record

ArticleInternational journal of molecular sciences2025

The Potential Contribution of the IL-37/IL-18/IL-18BP/IL-18R Axis in the Pathogenesis of Sjögren's Syndrome.

Dorian Parisis, Julie Sarrand, Muhammad Soyfoo

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Roles of Interleukin-18 in Inflammation and Autoimmune Disease.Clinical reviews in allergy & immunology · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dorian ParisisDepartment of Rheumatology, Hôpital Erasme, Hôpital Universitaire de Bruxelles HUB, Université Libre de Bruxelles ULB, 1070 Brussels, Belgium.
Julie SarrandDepartment of Rheumatology, Hôpital Erasme, Hôpital Universitaire de Bruxelles HUB, Université Libre de Bruxelles ULB, 1070 Brussels, Belgium.ORCID 0000-0002-6833-0044
Muhammad SoyfooDepartment of Rheumatology, Hôpital Erasme, Hôpital Universitaire de Bruxelles HUB, Université Libre de Bruxelles ULB, 1070 Brussels, Belgium.ORCID 0000-0002-9051-1810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to explore the expression profile of the Interleukin (IL)-37/IL-18/IL-18BP/IL-18R axis in patients with primary Sjögren's syndrome (pSS). This study included 36 patients diagnosed with pSS, 13 patients presenting with sicca symptoms without confirmed pSS, and 14 healthy controls. Serum concentrations of IL-37, IL-18, IL-18BP, and IL-18R were measured using a sandwich ELISA. These levels were then correlated with relevant clinical and biological parameters. Furthermore, expression of the same cytokines was assessed in salivary gland biopsies via immunohistochemistry. No significant difference in serum IL-37 levels was observed among the three groups (

Indexed as

Intercellular Signaling Peptides and ProteinsInterleukin-1Interleukin-18Sjogren's SyndromeAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedSalivary GlandsSignal TransductionIL18 protein, humanIL37 protein, humanIntercellular Signaling Peptides and ProteinsInterleukin-1Interleukin-18interleukin-18 binding proteinautoimmune diseaseimmunohistochemistryinflammation biomarkersinterleukin-18interleukin-37primary Sjögren’s syndromesalivary glands

Identifiers

PMID40430016
PMCPMC12112074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.